Word

Status

Pending

Status Code

630

Status Date

Monday, February 5, 2024

Serial Number

98349160

Mark Type

5

Filing Date

Tuesday, January 9, 2024

Trademark Owner History

Wave Life Sciences Ltd.

Classifications

5 Nucleic acid sequences and chemical reagents for medical purposes; pharmaceutical preparations for the treatment of genetic diseases and disorders; genetic medicines for the treatment of diseases and disorders with known genetic cause or component and disease states resulting from gene expression or genetic sequence; nucleic acid therapeutic agents for the treatment of Huntington's disease, Duchenne muscular dystrophy, and alpha-1 antitrypsin deficiency; pharmaceutical preparations for the prevention, diagnosis, and treatment of metabolic, cardiometabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, renal, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric, autoimmune, and immune system related diseases and disorders

42 Research and development in the fields of pharmaceuticals, genetics, therapeutics, and drug formulation and delivery; scientific research; scientific research in the fields of pharmaceuticals, medicine, and nucleic acid therapeutics; research, development, and testing services in the field of nucleic acid therapeutics for medical and scientific applications; medical research; laboratory research services relating to pharmaceuticals

The mark consists of the stylized letter "W".
WAVE
Color is not claimed as a feature of the mark.

Trademark Events

Jan 9, 2024

New Application Entered

Apr 28, 2024

New Application Office Supplied Data Entered